(Q33857658)

English

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Arturo Casadevall

5

object named as

Arturo Casadevall

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

object named as

John Perfect

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

Scott Filler

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

object named as

Judith A Aberg

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Peter G. Pappas

2

object named as

Peter G Pappas

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Robert A Larsen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gretchen A Cloud

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Robert James

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

William E Dismukes

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

952-958

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

THE FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. III. EXTRACELLULAR SPREAD OF CRYPTOCOCCAL POLYSACCHARIDES IN THE ACUTE STAGE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Immunoregulation by capsular components of Cryptococcus neoformans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Early mycological treatment failure in AIDS-associated cryptococcal meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Induction of Human Immunodeficiency Virus Type 1 Expression in Monocytic Cells byCryptococcus neoformansandCandida albicans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Human immune response to monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: study during murine cryptococcosis and mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Protective murine monoclonal antibodies to Cryptococcus neoformans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

Complement depletion in cryptococcal sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

5 July 2018

FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. VI. INTRACELLULAR ACCUMULATION OF FLUID AND CRYPTOCOCCAL POLYSACCHARIDE IN OLIGODENDROGLIA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. V. TRANSFER OF FLUID FROM EXTRACELLULAR TO INTRACELLULAR COMPARTMENTS IN ACUTE PHASE OF CRYPTOCOCCAL POLYSACCHARIDE LESIONS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=549259

29 October 2018

Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cryptococcal capsular polysaccharide utilizes an antigen-presenting cell to induce a T-suppressor cell to secrete TsF

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum therapy for Cryptococcal meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SERUM PROTEIN ENHANCEMENT OF ANTIBIOTIC THERAPY IN CRYPTOCOCCOSIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotype can affect the fine specificity of an antibody for a polysaccharide antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive immunization in murine cryptococcosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of mouse monoclonal antibody and human anti-mouse antibody response in serum of patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15728888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.3.952-958.2005

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33857658&oldid=1777325600"